Home › Funds › Cormorant Asset Management, LP › ERAS

Cormorant Asset Management, LP position in ERAS

ERASCA INC · Health Care

Cormorant Asset Management, LP reported holding 6,000,000 shares of ERAS (ERASCA INC) in its Q2 2026 13F filing — a position valued at US$109.9M, representing 5.63% of its reported portfolio and ranking #5 among its reported holdings. Cormorant Asset Management, LP has disclosed ERAS holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)6.00M sh
Reported value held$109.92M
Portfolio Weight5.63%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's ERAS position evolved

Cormorant Asset Management, LP first disclosed a stake in ERAS in Q3 2023 at 10,813,246 shares (US$21.3M). The position peaked in Q2 2026 at 6,000,000 shares, worth US$109.9M. Across 3 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,000,000 shares valued at US$109.9M — an increase of 200,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 10.81M $21.30M New
Q1 2026 5.80M $93.84M New
Q2 2026 6.00M $109.92M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has Cormorant Asset Management, LP held ERAS?

Cormorant Asset Management, LP has disclosed ERAS holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

What is Cormorant Asset Management, LP's current position in ERAS?

As of Q2 2026, Cormorant Asset Management, LP holds 6.00M shares of ERAS (ERASCA INC), valued at $109.92M, representing 5.63% of its reported portfolio and ranking #5.

Has Cormorant Asset Management, LP been buying or selling ERAS?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP increased its position in ERAS. The position peaked in Q2 2026 at 6.00M shares.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.